Hyaluronate compositions
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Aug 18, 2015
Issued Date -
N/A
app pub date -
Jun 12, 2013
filing date -
Jan 30, 2007
priority date (Note) -
In Force
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Patent Longevity
|
Forward Citations
|
Abstract
The present invention provides compositions suitable for topical administration to a mammalian subject including sodium hyaluronate and a pharmaceutically acceptable excipient. The present invention also provides methods for making and using the same.
First Claim
all claims..Other Claims data not available
Family

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
CURRAX PHARMACEUTICALS LLC | 10 NORTH PARK PLACE SUITE 201 MORRISTOWN NJ 07960 |
International Classification(s)
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
Lewis, Robert | Madison, US | 58 | 520 |
# of filed Patents : 58 Total Citations : 520 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 10 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Feb 18, 2027 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
Date | Code | Event | Description |
---|---|---|---|
Sep 25, 2023 | LAPS | LAPSE FOR FAILURE TO PAY MAINTENANCE FEES | free format text: PATENT EXPIRED FOR FAILURE TO PAY MAINTENANCE FEES (ORIGINAL EVENT CODE: EXP.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
Sep 25, 2023 | STCH | INFORMATION ON STATUS: PATENT DISCONTINUATION | free format text: PATENT EXPIRED DUE TO NONPAYMENT OF MAINTENANCE FEES UNDER 37 CFR 1.362 |
Aug 18, 2023 | FP | LAPSED DUE TO FAILURE TO PAY MAINTENANCE FEE | Effective Date: Aug 18, 2023 |
Apr 10, 2023 | FEPP | FEE PAYMENT PROCEDURE | free format text: MAINTENANCE FEE REMINDER MAILED (ORIGINAL EVENT CODE: REM.); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY |
Dec 13, 2019 | AS | ASSIGNMENT | free format text: SECURITY INTEREST;ASSIGNORS:CURRAX PHARMACEUTICALS LLC;NALPROPION PHARMACEUTICALS LLC;REEL/FRAME:051377/0958 Owner name: WILMINGTON SAVINGS FUND SOCIETY, FSB, DELAWARE Effective Date: Dec 13, 2019 |
Apr 25, 2019 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CYPRESS PHRAMACEUTICALS, INC.;REEL/FRAME:049329/0945 Owner name: CURRAX PHARMACEUTICALS LLC, NEW JERSEY Effective Date: Apr 25, 2019 |
Feb 07, 2019 | MAFP | MAINTENANCE FEE PAYMENT | free format text: PAYMENT OF MAINTENANCE FEE, 4TH YR, SMALL ENTITY (ORIGINAL EVENT CODE: M2551); ENTITY STATUS OF PATENT OWNER: SMALL ENTITY year of fee payment: 4 |
Aug 19, 2015 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PERNIX THERAPEUTICS HOLDINGS, INC.;REEL/FRAME:036387/0660 Owner name: CYPRESS PHARMACEUTICALS, INC., NEW JERSEY Effective Date: Aug 19, 2015 |
Aug 18, 2015 | I | Issuance | |
Jul 29, 2015 | STCF | INFORMATION ON STATUS: PATENT GRANT | free format text: PATENTED CASE |
Feb 27, 2014 | P | Published | |
Jun 12, 2013 | F | Filing | |
Dec 31, 2012 | AS | ASSIGNMENT | free format text: STOCK POWER/STOCK CERTIFICATES;ASSIGNOR:CYPRESS PHARMACEUTICALS, INC.;REEL/FRAME:032076/0271 Owner name: PERNIX THERAPEUTICS HOLDINGS, INC., TEXAS Effective Date: Dec 31, 2012 |
Feb 01, 2008 | AS | ASSIGNMENT | free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LEWIS, ROBERT;REEL/FRAME:030601/0867 Owner name: CYPRESS PHARMACEUTICALS, INC., MISSISSIPPI Effective Date: Feb 01, 2008 |

Matter Detail

Renewals Detail
